Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Galmed Pharmaceuticals Ltd. logo

Galmed Pharmaceuticals Ltd.

Sector: Healthcare   

Industry: Biotechnology

4.60
 
USD
  
-0.50
  
(-9.81%)
Optionable: Yes  Market Cap: 105 M  90-day average vol: 341,522

Previous close: 5.1001  Open: 5.32  Bid: 3.79  Ask: 6.01
52 week range    
0.29   
   5.63
Peers   
ENDP / 
AERI / 
EVOK / 
Last updated: Sunday 28th May 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AERI

0 B-27.24

EGRX

1 B114.945.59

ENDP

1 B11.43.14

EVOK

0 B-1.80.54
Financials

GLMD Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Total revenues0004670001 M2 M0000
Cost of sales-4000-9000-142000-213000-260000-24300070000-129000-163000-33000
Gross operating profit0004670001 M2 M0000
Selling Gen & administrative expense7 M2 M3 M3 M4 M4 M4 M4 M6 M5 M
Research & development expense7 M7 M8 M14 M10 M8 M18 M26 M27 M13 M
Operating income-15 M-9 M-11 M-17 M-12 M-11 M-22 M-30 M-33 M-18 M
floaterest income0000000000
floaterest expense0000000000
Other income net-1000000-280000-8800017000-5000278000-105000-490000
Pre-tax Income (EBT)-17 M-9 M-11 M-17 M-12 M-10 M-20 M-29 M-32 M-18 M
Income taxes1000100001060000750000000
Net income from total operations-17 M-9 M-11 M-17 M-12 M-10 M-20 M-29 M-32 M-18 M
Minority floaterest0000000000
Total net income-17 M-9 M-11 M-17 M-12 M-10 M-20 M-29 M-32 M-18 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-17 M-9 M-11 M-17 M-12 M-10 M-20 M-29 M-32 M-18 M
Depreciation40009000142000213000260000243000-7000012900016300033000
Amortization0000000000
Operating income before depreciation (EBITDA)-15 M-9 M-11 M-17 M-12 M-10 M-22 M-30 M-33 M-18 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-3.45-0.88-0.96-1.49-0.98-0.54-0.97-1.35-1.32-0.71
Diluted EPS total-3.45-0.88-0.96-1.49-0.98-0.54-0.97-1.35-1.32-0.71
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today